General Information of Drug (ID: DM3Q1FT)

Drug Name
PMID28766366-Compound-Scheme27LeucettamineB Drug Info
Cross-matching ID
PubChem CID
10037501
TTD Drug ID
DM3Q1FT

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Harmine DMPA5WD Discovery agent N.A. Patented [1]
PMID28766366-Compound-Scheme21Left DMWTRUK N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme21Right DMF3X40 N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme14BINDY DMBQ0RN N. A. N. A. Patented [1]
TG003 DMP4HR2 Discovery agent N.A. Patented [1]
PMID28766366-Compound-Scheme2WO2012/098065bottom DMO4Q95 N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme16DMAT DMQ5UEA N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme7WO2012/098070upper DMGAQR5 N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme9EHT1610 DMMZGC8 N. A. N. A. Patented [1]
PMID28766366-Compound-Scheme9EHT5372 DM0O18N N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) TTSBVFO DYR1A_HUMAN Inhibitor [1]

References

1 Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199.